| 1 day | -16.59% |
| Manager | Title | Age | Since |
|---|---|---|---|
Carl Merton
CEO | Chief Executive Officer | 57 | 2023-06-21 |
Pamela McRae
CTO | Chief Tech/Sci/R&D Officer | - | - |
Richard Redekop
COO | Chief Operating Officer | - | 2022-06-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Vincent Chiara
BRD | Director/Board Member | - | 2016-11-03 |
Peter Montour
BRD | Director/Board Member | - | 2021-08-29 |
William Montour
BRD | Director/Board Member | - | 2022-01-04 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 23-05-01 | Other | Director | 0 | 0% | ||
| 23-04-27 | Option | Director | 35,622 | 0.0830% | ||
| 23-04-27 | Option | Director | 25,192 | 0.0587% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -16.59% | -39.87% | - | - | 29.39M | ||
| +3.89% | +0.71% | +329.09% | +17.12% | 2.64B | ||
| +5.52% | -10.99% | +155.40% | +127.02% | 1.73B | ||
| +0.43% | -9.89% | -18.85% | +135.33% | 459M | ||
| 0.00% | +6.67% | +23.08% | -4.00% | 51.65M | ||
| Average | -1.35% | -3.08% | +122.18% | +68.87% | 1.22B | |
| Weighted average by Cap. | +3.98% | -3.53% | +231.50% | +67.00% |
Employees
-
Sector
Pharmaceuticals
















